Evidence map›Paper›PMID 27455951›Full record

ArticleThe Journal of experimental medicine2016

High antigen levels induce an exhausted phenotype in a chronic infection without impairing T cell expansion and survival.

Daniel T Utzschneider, Francesca Alfei, Patrick Roelli, David Barras, Vijaykumar Chennupati, Stephanie Darbre, Mauro Delorenzi, Daniel D Pinschewer, Dietmar Zehn

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 118 papers.

0numbers the graph read from it
0cells of the map it votes in
118citing papers in PubMed
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

118 citing papers in PubMed, 170 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Upregulation of TNFR2 Precedes TOX Expression by Exhausted T cells and Restricts Antitumor and Antiviral Immunity.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. The diversity of CD8Nature reviews. Immunology · 2025
    Review
  18. Article
  19. Article
  20. Article

58 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Daniel T UtzschneiderSwiss Vaccine Research Institute, 1066 Epalinges, Switzerland Division of Immunology and Allergy, Department of Medicine, Lausanne University Hospital, 1011 Lausanne, Switzerland.ORCID 0000-0003-2205-9057
Francesca AlfeiSwiss Vaccine Research Institute, 1066 Epalinges, Switzerland Division of Immunology and Allergy, Department of Medicine, Lausanne University Hospital, 1011 Lausanne, Switzerland.
Patrick RoelliSwiss Vaccine Research Institute, 1066 Epalinges, Switzerland Division of Immunology and Allergy, Department of Medicine, Lausanne University Hospital, 1011 Lausanne, Switzerland Bioinformatics Core Facility, SIB Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.
David BarrasBioinformatics Core Facility, SIB Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.ORCID 0000-0001-8985-4704
Vijaykumar ChennupatiSwiss Vaccine Research Institute, 1066 Epalinges, Switzerland Division of Immunology and Allergy, Department of Medicine, Lausanne University Hospital, 1011 Lausanne, Switzerland Ludwig Center for Cancer Research, University of Lausanne, 1015 Lausanne, Switzerland.ORCID 0000-0003-0014-3274
Stephanie DarbreDepartment of Pathology and Immunology, University of Geneva, 1211 Geneva, Switzerland World Health Organization Collaborating Center for Vaccine Immunology, University of Geneva, 1211 Geneva, Switzerland.ORCID 0000-0002-0817-0472
Mauro DelorenziLudwig Center for Cancer Research, University of Lausanne, 1015 Lausanne, Switzerland Faculty of Biology and Medicine, Department of Oncology, University of Lausanne, 1015 Lausanne, Switzerland Bioinformatics Core Facility, SIB Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.
Daniel D PinschewerDivision of Experimental Virology, Department of Biomedicine, University of Basel, 4003 Basel, Switzerland.
Dietmar ZehnSwiss Vaccine Research Institute, 1066 Epalinges, Switzerland Division of Immunology and Allergy, Department of Medicine, Lausanne University Hospital, 1011 Lausanne, Switzerland dietmar.zehn@tum.de.
Swiss Vaccine Research Institute · CHSIB Swiss Institute of Bioinformatics · CHUniversity of Basel · CHUniversity of Geneva · CH

Funding

European Research Council 337043
6 · The paper itself

Abstract

Chronic infections induce T cells showing impaired cytokine secretion and up-regulated expression of inhibitory receptors such as PD-1. What determines the acquisition of this chronic phenotype and how it impacts T cell function remain vaguely understood. Using newly generated recombinant antigen variant-expressing chronic lymphocytic choriomeningitis virus (LCMV) strains, we uncovered that T cell differentiation and acquisition of a chronic or exhausted phenotype depend critically on the frequency of T cell receptor (TCR) engagement and less significantly on the strength of TCR stimulation. In fact, we noted that low-level antigen exposure promotes the formation of T cells with an acute phenotype in chronic infections. Unexpectedly, we found that T cell populations with an acute or chronic phenotype are maintained equally well in chronic infections and undergo comparable primary and secondary expansion. Thus, our observations contrast with the view that T cells with a typical chronic infection phenotype are severely functionally impaired and rapidly transition into a terminal stage of differentiation. Instead, our data unravel that T cells primarily undergo a form of phenotypic and functional differentiation in the early phase of a chronic LCMV infection without inheriting a net survival or expansion deficit, and we demonstrate that the acquired chronic phenotype transitions into the memory T cell compartment.

Indexed as

AnimalsAntigens, CDAntigens, ViralCell DifferentiationCell SurvivalChronic DiseaseInterleukin-7 Receptor alpha SubunitLymphocyte ActivationLymphocyte Activation Gene 3 ProteinLymphocytic ChoriomeningitisLymphocytic choriomeningitis virusMiceMice, Inbred C57BLPhenotypeProgrammed Cell Death 1 ReceptorReceptors, Antigen, T-CellAntigens, CDAntigens, ViralInterleukin-7 Receptor alpha SubunitLymphocyte Activation Gene 3 ProteinPdcd1 protein, mouseProgrammed Cell Death 1 ReceptorReceptors, Antigen, T-Cell

Identifiers

PMID27455951
PMCPMC4995073
OpenAlexW2503575190

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.